Abstract
Gastroesophageal reflux disease (GERD) and obesity coexist in many patients. The association is not coincidental, since obesity plays a major role in the pathophysiology of GERD. Obesity is associated with a higher number of transient lower esophageal sphincter relaxations and abnormal peristalsis. Central obesity increases the trans-diaphragmatic pressure gradient and disrupts the anatomy of the gastroesophageal junction by causing hiatal hernia formation. Obese patients benefit from weight loss: this can be achieved by diet and exercise but bariatric surgery today plays an important role, as it determines a more pronounced and durable weight loss and partial or complete resolution of most obesity-associated comorbidities. Today, laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass are the most common bariatric operations used for the treatment of morbidly obese patients.
This chapter focuses on the pathophysiology of GERD in obese patients and on the impact of both sleeve gastrectomy and Roux-en-Y gastric bypass on GERD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63:871–80.
Zvenyach T, Pickering MK. Health care quality: measuring obesity in performance frameworks. Obesity. 2017;25:1305–12.
Chang P, Friedenberg F. Obesity and GERD. Gastroenterol Clin N Am. 2014;43:161–73.
Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA Jr. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med. 2006;354:2340–8.
Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143:199–211.
Stein DJ, El-Serag HB, Kuczynski J, et al. The association of body mass index with Barrett’s oesophagus. Aliment Pharmacol Ther. 2005;22:1005–10.
Corley DA, Kubo A, Levin TR. Abdominal obesity and body mass index as risk factors for Barrett’s esophagus. Gastroenterology. 2007;133:34–41.
Pohl H, Wrobel K, Bojarski C, et al. Risk factors in the development of esophageal adenocarcinoma. Am J Gastroenterol. 2013;108:200–7.
Hoyo C, Cook MB, Kamangar F, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol. 2012;41:1706–18.
Quiroga E, Cuenca-Abente F, Flum D. Impaired esophageal function in morbidly obese patients with gastroesophageal reflux disease: evaluation with multichannel intraluminal impedance. Surg Endosc. 2006;20:739–43.
Herbella FA, Sweet MP, Tedesco P, Nipomnick I, Patti MG. Gastroesophageal reflux disease and obesity. Pathophysiology and implications for treatment. J Gastrointest Surg. 2007;11:286–90.
Valezi AC, Herbella FA, Junior JM, de Almeida Menezes M. Esophageal motility after laparoscopic Roux-en-Y gastric bypass: the manometry should be preoperative examination routine? Obes Surg. 2012;22:1050–4.
Wu JC, Mui LM, Cheung CM, Chan Y, Sung JJ. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology. 2007;132:883–9.
Schneider JH, Keuper M, Keonigsrainer A, Breucher B. Transient lower esophageal sphincter relaxation in morbid obesity. Obes Surg. 2009;19:595–600.
Lee YY, McColl KEL. Pathophysiology of gastroesophageal reflux disease. Best Pract Res Clin Gastroenterol. 2013;27:339–51.
Richter JE, Rubenstein JH. Gstroesophageal reflux disease – presentation and epidemiology of gastroesophageal reflux disease. Gastroenterology. 2018;154:267–76.
Valezi AC, Herbella FA, Mali J Jr. Gastroesophageal reflux disease: pathophysiology. In: Fisichella PM, Allaix ME, Morino M, Patti MG, editors. Esophageal diseases. Evaluation and treatment. New York: Springer; 2014. p. 41–51.
Suter M, Dorta G, Giusti V, et al. Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients. Obes Surg. 2004;14:959–66.
Herbella FA, Patti MG. Gastroesophageal reflux disease: from pathophysiology to treatment. World J Gastroenterol. 2010;16:3745–9.
Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, Kahrilas PJ. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006;130:639–49.
Cote-Daigneault J, Leclerc P, Joubert J, Bouin M. High prevalence of esophageal dysmotility in asymptomatic obese patients. Can J Gastroenterol Hepatol. 2014;28:311–4.
Koppman JS, Poggi L, Szomstein S, et al. Esophageal motility disorders in the morbidly obese population. Surg Endosc. 2007;21:761–4.
Gourcerol G, Benanni Y, Boueyre E, Leroi AM, Ducrotte P. Influence of gastric emptying on gastroesophageal reflux: a combined pH-impedance study. Neurogastroenterol Motil. 2013;25:800–4.
Buchholz V, Berkenstadt H, Goitein D, Dickman R, Bernstine H, Rubin M. Gastric emptying is not prolonged in obese patients. Surg Obes Relat Dis. 2013;9:714–7.
Mushref MA, Srinivasan S. Effect of high fat-diet and obesity on gastrointestinal motility. Ann Transl Med. 2013;1:14–7.
Nadaleto BF, Herbella FAM, Patti MG. Gastroesophageal reflux disease in the obese: pathophysiology and treatment. Surgery. 2016;159:475–86.
Shepherd K, Hillman D, Holloway R, Eastwood P. Mechanisms of nocturnal gastroesophageal reflux events in obstructive sleep apnea. Sleep Breath. 2011;15:561–70.
Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6:772–83.
Mion F, Dargent J. Gastro-oesophageal reflux disease and obesity: pathogenesis and response to treatment. Best Pract Res Clin Gastroenterol. 2014;28:611–22.
Knowles CH, Aziz Q. Visceral hypersensitivity in non-erosive reflux disease. Gut. 2008;57:674–83.
Velden vd A, de Wit NJ, Quartero AO. Maintenance treatment for GERD: residual symptoms are associated with psychological distress. Digestion. 2008;77:207–13.
Schey R, Dickman R, Parthasarathy S. Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology. 2007;133:1787–95.
Fass R, Naliboff BD, Fass SS. The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease. Gastroenterology. 2008;134:696–705.
De Groot NL, Burgerhart JS, Van De Meeberg PC, de Vries DR, Smout AJ, Siersema PD. Systematic review: the effects of conservative and surgical treatment for obesity on gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2009;30:1091–102.
Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med. 2006;166:965–71.
Rosenthal RJ, International Sleeve Gastrectomy Expert Panel, Diaz AA, Arvidsson D, Baker RS, Basso N. International sleeve gastrectomy expert panel consensus statement: best practice guidelines based on experience of >12,000 cases. Surg Obes Relat Dis 2012;8:8–19.
Soricelli E, Iossa A, Casella G, Abbatini F, Cali B, Basso N. Sleeve gastrectomy and crural repair in obese patients with gastroesophageal reflux disease and/or hiatal hernia. Surg Obes Relat Dis. 2013;9:356–61.
Braghetto I, Csendes A, Korn O, Valladares H, Gonzalez P, Henriquez A. Gastroesophageal reflux disease after sleevebgastrectomy. Surg Laparosc Endosc Percutan Tech. 2010;20:148–53.
Fraser-Moodie CA, Norton B, Gornall C. Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweight. Scand J Gastroenterol. 1999;34:337–40.
Burton PR, Brown WA, Laurie C, Korin A, Yap K, Richards M. Pathophysiology of laparoscopic adjustable gastric bands: analysis and classification using high-resolution video manometry and a stress barium protocol. Obes Surg. 2010;20:19–29.
Cruiziat C, Roman S, Robert M, Espalieu P, Laville M, Poncet G. High resolution esophageal manometry evaluation in symptomatic patients after gastric banding for morbid obesity. Dig Liver Dis. 2011;43:116–20.
Tandon A, Rao R, Hotouras A, Nunes QM, Hartley M, Gunasekera R, Howes N. Safety and effectiveness of antireflux surgery in obese patients. Ann R Coll Surg Engl. 2017;99:515–23.
Mandeville Y, Looveren R, Vancoillie PJ, et al. Moderating the enthusiasm of sleeve gastrectomy: up to fifty percent of reflux symptoms after ten years in a consecutive series of one hundred laparoscopic sleeve gastrectomy. Obes Surg. 2017;27:1797–803.
Genco A, Soricelli E, Casella G, et al. Gastroesophageal reflux disease and Barrett’s esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication. Surg Obes Relat Dis. 2017;13:568–74.
Rebecchi F, Allaix ME, Giaccone C, Ugliono E, Scozzari G, Morino M. Gastroesophageal reflux disease and laparoscopic sleeve gastrectomy. A physiopathologic evaluation. Ann Surg. 2014;260:909–15.
Conflict of Interest
The authors have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Patti, M.G., Schlottmann, F., Farrell, T.M. (2020). Pathophysiology of Gastroesophageal Reflux Disease in Obese Patients. In: Gagner, M., Cardoso, A., Palermo, M., Noel, P., Nocca, D. (eds) The Perfect Sleeve Gastrectomy. Springer, Cham. https://doi.org/10.1007/978-3-030-28936-2_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-28936-2_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-28935-5
Online ISBN: 978-3-030-28936-2
eBook Packages: MedicineMedicine (R0)